Low previous cardiovascular risk of patients with ST-elevation myocardial infarction
Gustavo Rodrigues1, Pedro de Araújo Gonçalves, Francisco Moscoso Costa
1aHospital Centre of Western Lisbon (CHLO), Santa Cruz Hospital bChronic Diseases Research Center (CEDOC), Nova Medical School, Lisbon, Portugal.
Insights
The Systemic Coronary Risk Estimation (SCORE) tool underestimated cardiovascular risk in patients experiencing ST-elevation myocardial infarction (STEMI) as their first coronary artery disease (CAD) event. This highlights the need for improved risk stratification tools in primary prevention.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Coronary artery disease (CAD) often presents initially as myocardial infarction.
- Systemic Coronary Risk Estimation (SCORE) risk tables are standard for primary cardiovascular (CV) risk assessment.
- Accurate CV risk stratification is crucial for effective primary prevention strategies.
Purpose of the Study:
- To evaluate the performance of the SCORE risk charts in estimating CV risk for patients presenting with ST-elevation myocardial infarction (STEMI) as their first manifestation of CAD.
- To assess the accuracy of pre-event SCORE calculations in identifying individuals at high risk for future cardiovascular events.
Main Methods:
- Analysis of a prospective registry of 3056 patients with STEMI undergoing coronary angiography (2004-2014).
- Inclusion of 1628 patients with STEMI as their first CAD manifestation, excluding those with prior CAD, high-risk equivalents, or normal coronaries.
- Calculation of individual SCORE risk profiles using pre-event data for risk stratification into low, high, and very high-risk categories.
Main Results:
- Over two-thirds of patients (71.4%) with STEMI as their first CAD event were classified as low risk (SCORE < 5%) prior to the event.
- Only a small proportion (3.5%) were classified as very high risk (SCORE ≥ 10%).
- The majority of STEMI patients, when assessed pre-event using SCORE, fell into lower risk categories than their actual event indicated.
Conclusions:
- The SCORE risk charts significantly underestimate CV risk in patients experiencing STEMI as their first CAD manifestation.
- Current risk stratification tools may not adequately identify individuals who will experience a first STEMI event.
- There is a critical need for enhanced primary prevention strategies and additional tools to improve the identification of high-risk individuals for cardiovascular events.
Background:
Myocardial infarction is frequently the initial form of presentation of coronary artery disease (CAD). Systemic Coronary Risk Estimation (SCORE) risk tables are used in primary prevention and provide an estimate of cardiovascular (CV) risk through known risk factors. The aim of this study was to evaluate the performance of the SCORE, calculated using data previous to the event, to estimate CV risk of a population of patients presenting with ST-elevation myocardial infarction (STEMI) as the first manifestation of CAD.
Methods And Results:
From a prospective registry including 3056 patients with STEMI subjected to coronary angiography between 2004 and 2014, 1628 patients with STEMI as the first manifestation of CAD were included after the exclusion of patients with known CAD (n=748, 24.5%), patients with high-risk equivalents (n=930, 30.4%), and patients with normal coronaries (n=57, 1.87%). The individual risk profile was calculated using data previous to the event and patients were classified into three established subgroups: low risk (SCORE<5%; n=1162, 71.4%), high risk (SCORE 5-10%; n=409, 25.1%), and very high risk (SCORE≥10%; n=57, 3.5%).
Conclusion:
In a population of patients with STEMI as the first manifestation of CAD, the CV risk stratification with the SCORE risk charts, if calculated before the event, would classify as low risk more than two-thirds of the patients (71.4%) and only 3.5% would be classified as very high-risk patients. The high prevalence of low-risk patients indicates the current challenge of CV risk stratification, underlying the need for additional tools in primary prevention to better identify patients at risk.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis III: Management
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations


